SS Innovation(Sudhir Srivastava Innovations)

Embodied AI & Robotics
Post-IPO Private PlacementUSD 19M2026-03-19

SEC Form D filing: USD 18,621,498 offering, Rule 506(b) exemption, 25 investors, sales commission USD 175,000. This is the largest filed financing since the IPO and the primary incremental funding channel for the company since listing on Nasdaq. Source: SEC EDGAR Form D (CIK 0001676163)

View funding history →
Valuation
USD 250M

Company Profile

SS Innovation develops minimally invasive surgical robots in India since 2019. Their systems target precise operations in urology and gynecology, aiming to reduce procedure costs and improve healthcare accessibility at the grassroots level through advanced soft-tissue manipulation technologies.

Founded
2019
Headquarters
India